Triple-Negative Breast Cancer Treatment Market to Witness an Outstanding Growth by 2016-2024 - Persistence Market Research
According to the research article published in Journal of the Moffitt Cancer Center, around 1 million breast cancers are diagnosed globally among them 1.7% of cancer cases are triple-negative cancers. Triple-negative breast cancers are more aggressive and fewer survival rates when compared with breast cancer. Increase in incidence of breast cancers globally, and higher mortality rates related to breast cancers in developing countries are projected to driving the growth of this market during the forecast period. Lack of treatment regimens...
View full press release